Roivant Sciences Ltd’s recently made public that its 10% Owner Ramaswamy Vivek unloaded Company’s shares for reported $6.99 million on May 07 ’25. In the deal valued at $11.18 per share,625,000 shares were sold. As a result of this transaction, Ramaswamy Vivek now holds 39,174,611 shares worth roughly $416.82 million.
Then, Ramaswamy Vivek sold 273,959 shares, generating $3,142,310 in total proceeds. Upon selling the shares at $11.47, the 10% Owner now owns 39,799,611 shares.
Before that, Ramaswamy Vivek bought 625,000 shares. Roivant Sciences Ltd shares valued at $6,987,388 were divested by the 10% Owner at a price of $11.18 per share.
Wolfe Research initiated its Roivant Sciences Ltd [ROIV] rating to an Outperform in a research note published on February 15, 2024; the price target was $17. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. Deutsche Bank began covering ROIV with “Buy” recommendation on December 12, 2023. Guggenheim started covering the stock on October 17, 2023. It rated ROIV as “a Buy”.
Price Performance Review of ROIV
On Friday, Roivant Sciences Ltd [NASDAQ:ROIV] saw its stock fall -3.54% to $10.64. Over the last five days, the stock has lost -7.32%. Roivant Sciences Ltd shares have fallen nearly -10.06% since the year began. Nevertheless, the stocks have fallen -6.50% over the past one year. While a 52-week high of $13.06 was reached on 01/02/25, a 52-week low of $8.73 was recorded on 04/07/25. SMA at 50 days reached $10.53, while 200 days put it at $11.26.
Levels Of Support And Resistance For ROIV Stock
The 24-hour chart illustrates a support level at 10.45, which if violated will result in even more drops to 10.26. On the upside, there is a resistance level at 11.00. A further resistance level may holdings at 11.36. The Relative Strength Index (RSI) on the 14-day chart is 47.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.18, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.07%. Stochastics %K at 50.93% indicates the stock is a holding.
The most recent change occurred on June 08, 2023 when BofA Securities began covering the stock and recommended ‘”a Neutral”‘ rating along with a $10.50 price target.
